Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Mechanisms of SGLT inhibitor action and physiological mediators: systematic review and protocol for the MOSAIC collaborative meta-analysis.
Journal: BMJ open
Published: February 26, 2026
Mechanisms of SGLT inhibitor action and physiological mediators: systematic review and protocol for the MOSAIC collaborative meta-analysis.
Journal: BMJ open
Published: February 26, 2026
Role of the kidney in glucose homeostasis: the basis for pharmacotherapy and prevention of cardiorenal complications in diabetes.
Journal: Kidney international
Published: November 19, 2025
Changes in β-Cell Function and Insulin Sensitivity During Treatment With Dapagliflozin Alone or in Combination With Exenatide in Type 2 Diabetes.
Journal: Diabetes care
Published: February 27, 2025
Effect of dapagliflozin on renal haemodynamics in hyperfiltering T2D patients.
Journal: Diabetes, obesity & metabolism
Published: September 30, 2024
Mesenteric Visceral Lipectomy Improves Glucose Tolerance in Patients With Type 2 Diabetes: A Pilot Study.
Journal: The Journal of clinical endocrinology and metabolism
Published: July 18, 2024
Effect of Hyperketonemia on Myocardial Function in Patients With Heart Failure and Type 2 Diabetes.
Journal: Diabetes
Published: May 14, 2024
Effect of weight-maintaining ketogenic diet on glycemic control and insulin sensitivity in obese T2D subjects.
Journal: BMJ open diabetes research & care
Published: March 14, 2024
Effect of Dapagliflozin on Renal and Hepatic Glucose Kinetics in T2D and NGT Subjects.
Journal: Diabetes
Published: June 09, 2023
Emergence of a New Glucoregulatory Mechanism for Glycemic Control With Dapagliflozin/Exenatide Therapy in Type 2 Diabetes.
Journal: The Journal of clinical endocrinology and metabolism
Published: May 08, 2023
Pioglitazone reduces epicardial fat and improves diastolic function in patients with type 2 diabetes.
Journal: Diabetes, obesity & metabolism
Published: July 26, 2022
Bromocriptine-QR Therapy Reduces Sympathetic Tone and Ameliorates a Pro-Oxidative/Pro-Inflammatory Phenotype in Peripheral Blood Mononuclear Cells and Plasma of Type 2 Diabetes Subjects.
Journal: International journal of molecular sciences
Published: July 11, 2022
Last Updated: 09/26/2026